Nov

29

Anti-Cancer Drug??

Filed Under Biotechnology & Drugs 

Ever heard of Callisto Pharmaceuticals, Inc. (Symbol: KAL)…..??

They are one of the companies who are currently in developing new drug treatments in the fight against cancer and other serious health threats. They recently announced that their anti-cancer drug candidate Atiprimod has been further recognized by the scientific community - which is going to lead them to a second oral presentation of research data at the annual meeting of American Society of Hematology (ASH) in Atlanta, GA.

They are also going to present findings of an animal-based study to investigate the effet of Atiprimod on multiple myeloma tumors (which is also known as incurable form of blood cancer). The animal study observed that Atiprimod produced experimentally significant reduction in tumor levels.

The stock is currently traded at $1.1/share. I’m not really sure when the price is going to hit through the roof; however, one thing for sure is this stock is definitely a great long-term investment.

Quote of the Day:
In the search for companies to acquire, we adopt the same attitude one might find appropriate in looking for a spouse: it pays to be active, interested, and open-minded, but it does not pay to be in a hurry. - Warren Buffett

Comments

Leave a Reply